메뉴 건너뛰기




Volumn 6, Issue 3, 2010, Pages 117-126

Cost-effectiveness of recombinant tissue plasminogen activator in the management of acute ischemic stroke: A systematic review

Author keywords

Cost effectiveness analysis; Recombinant tissue plasminogen activator; Stroke; Thrombolysis

Indexed keywords


EID: 78651497563     PISSN: 17386586     EISSN: 20055013     Source Type: Journal    
DOI: 10.3988/jcn.2010.6.3.117     Document Type: Review
Times cited : (26)

References (43)
  • 1
    • 56749186025 scopus 로고    scopus 로고
    • Six-year survival and causes of death among stroke patients in Korea
    • Kim HC, Choi DP, Ahn SV, Nam CM, Suh I. Six-year survival and causes of death among stroke patients in Korea. Neuroepidemiology 2009;32:94-100.
    • (2009) Neuroepidemiology , vol.32 , pp. 94-100
    • Kim, H.C.1    Choi, D.P.2    Ahn, S.V.3    Nam, C.M.4    Suh, I.5
  • 2
    • 51649101163 scopus 로고    scopus 로고
    • Factors affecting the quality of life after ischemis stroke: Young versus old patients
    • Kim JS, Choi-Kwon S, Kwon SU, Lee HJ, Park KA, Seo YS. Factors affecting the quality of life after ischemis stroke: young versus old patients. J Clin Neurol 2005;1:59-68.
    • (2005) J Clin Neurol , vol.1 , pp. 59-68
    • Kim, J.S.1    Choi-Kwon, S.2    Kwon, S.U.3    Lee, H.J.4    Park, K.A.5    Seo, Y.S.6
  • 3
    • 0029126086 scopus 로고
    • Costs of medical care after first-ever stroke in The Netherlands
    • Bergman L, van der Meulen JH, Limburg M, Habbema JD. Costs of medical care after first-ever stroke in The Netherlands. Stroke 1995; 26:1830-1836.
    • (1995) Stroke , vol.26 , pp. 1830-1836
    • Bergman, L.1    van der Meulen, J.H.2    Limburg, M.3    Habbema, J.D.4
  • 4
    • 60549115271 scopus 로고    scopus 로고
    • Cost-effectiveness of stroke unit care followed by early supported discharge
    • Saka O, Serra V, Samyshkin Y, McGuire A, Wolfe CC. Cost-effectiveness of stroke unit care followed by early supported discharge. Stroke 2009;40:24-29.
    • (2009) Stroke , vol.40 , pp. 24-29
    • Saka, O.1    Serra, V.2    Samyshkin, Y.3    McGuire, A.4    Wolfe, C.C.5
  • 5
    • 0033790923 scopus 로고    scopus 로고
    • Cost-effectiveness of stroke prevention
    • Ebrahim S. Cost-effectiveness of stroke prevention. Br Med Bull 2000;56:557-570.
    • (2000) Br Med Bull , vol.56 , pp. 557-570
    • Ebrahim, S.1
  • 6
    • 15244364036 scopus 로고    scopus 로고
    • Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: An economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA)
    • Lindgren P, Buxton M, Kahan T, Poulter NR, Dahlöf B, Sever PS, et al. Cost-effectiveness of atorvastatin for the prevention of coronary and stroke events: an economic analysis of the Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). Eur J Cardiovasc Prev Rehabil 2005;12:29-36.
    • (2005) Eur J Cardiovasc Prev Rehabil , vol.12 , pp. 29-36
    • Lindgren, P.1    Buxton, M.2    Kahan, T.3    Poulter, N.R.4    Dahlöf, B.5    Sever, P.S.6
  • 7
    • 21744455933 scopus 로고    scopus 로고
    • The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: Results from the Study on COgnition and Prognosis in the Elderly
    • Lundkvist J, Ekman M, Kartman B, Carlsson J, Jönsson L, Lithell H. The cost-effectiveness of candesartan-based antihypertensive treatment for the prevention of nonfatal stroke: results from the Study on COgnition and Prognosis in the Elderly. J Hum Hypertens 2005;19: 569-576.
    • (2005) J Hum Hypertens , vol.19 , pp. 569-576
    • Lundkvist, J.1    Ekman, M.2    Kartman, B.3    Carlsson, J.4    Jönsson, L.5    Lithell, H.6
  • 8
    • 33749324872 scopus 로고    scopus 로고
    • The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US
    • Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics 2006;24: 1021-1033.
    • (2006) Pharmacoeconomics , vol.24 , pp. 1021-1033
    • Sullivan, P.W.1    Arant, T.W.2    Ellis, S.L.3    Ulrich, H.4
  • 10
    • 34147112705 scopus 로고    scopus 로고
    • Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack
    • Meenan RT, Saha S, Chou R, Swarztrauber K, Pyle Krages K, O'Keeffe-Rosetti MC, et al. Cost-effectiveness of echocardiography to identify intracardiac thrombus among patients with first stroke or transient ischemic attack. Med Decis Making 2007;27:161-177.
    • (2007) Med Decis Making , vol.27 , pp. 161-177
    • Meenan, R.T.1    Saha, S.2    Chou, R.3    Swarztrauber, K.4    Pyle Krages, K.5    O'Keeffe-Rosetti, M.C.6
  • 11
    • 26444503709 scopus 로고    scopus 로고
    • Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation
    • Wilson RD, Murray PK. Cost-effectiveness of screening for deep vein thrombosis by ultrasound at admission to stroke rehabilitation. Arch Phys Med Rehabil 2005;86:1941-1948.
    • (2005) Arch Phys Med Rehabil , vol.86 , pp. 1941-1948
    • Wilson, R.D.1    Murray, P.K.2
  • 12
    • 63849312619 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke
    • Patil CG, Long EF, Lansberg MG. Cost-effectiveness analysis of mechanical thrombectomy in acute ischemic stroke. J Neurosurg 2009; 110:508-513.
    • (2009) J Neurosurg , vol.110 , pp. 508-513
    • Patil, C.G.1    Long, E.F.2    Lansberg, M.G.3
  • 13
    • 0031946671 scopus 로고    scopus 로고
    • Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group
    • Fagan SC, Morgenstern LB, Petitta A, Ward RE, Tilley BC, Marler JR, et al. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology 1998;50: 883-890.
    • (1998) Neurology , vol.50 , pp. 883-890
    • Fagan, S.C.1    Morgenstern, L.B.2    Petitta, A.3    Ward, R.E.4    Tilley, B.C.5    Marler, J.R.6
  • 14
    • 0034798437 scopus 로고    scopus 로고
    • Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: A Canadian healthcare perspective
    • Sinclair SE, Frighetto L, Loewen PS, Sunderji R, Teal P, Fagan SC, et al. Cost-Utility analysis of tissue plasminogen activator therapy for acute ischaemic stroke: a Canadian healthcare perspective. Pharmacoeconomics 2001;19:927-936.
    • (2001) Pharmacoeconomics , vol.19 , pp. 927-936
    • Sinclair, S.E.1    Frighetto, L.2    Loewen, P.S.3    Sunderji, R.4    Teal, P.5    Fagan, S.C.6
  • 15
    • 0036217797 scopus 로고    scopus 로고
    • Development of a decision-analytic model of stroke care in the United States and Europe
    • Chambers MG, Koch P, Hutton J. Development of a decision-analytic model of stroke care in the United States and Europe. Value Health 2002; 5:82-97.
    • (2002) Value Health , vol.5 , pp. 82-97
    • Chambers, M.G.1    Koch, P.2    Hutton, J.3
  • 16
    • 2542530145 scopus 로고    scopus 로고
    • Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs
    • Sandercock P, Berge E, Dennis M, Forbes J, Hand P, Kwan J, et al. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs. Stroke 2004;35:1490-1497.
    • (2004) Stroke , vol.35 , pp. 1490-1497
    • Sandercock, P.1    Berge, E.2    Dennis, M.3    Forbes, J.4    Hand, P.5    Kwan, J.6
  • 17
    • 0042431628 scopus 로고    scopus 로고
    • Stroke: Effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations
    • Stahl JE, Furie KL, Gleason S, Gazelle GS. Stroke: effect of implementing an evaluation and treatment protocol compliant with NINDS recommendations. Radiology 2003;228:659-668.
    • (2003) Radiology , vol.228 , pp. 659-668
    • Stahl, J.E.1    Furie, K.L.2    Gleason, S.3    Gazelle, G.S.4
  • 18
    • 2142643205 scopus 로고    scopus 로고
    • Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke
    • Moodie ML, Carter R, Mihalopoulos C, Thrift AG, Chambers BR, Donnan GA, et al. Trial application of a Model of Resource Utilization, Costs, and Outcomes for Stroke (MORUCOS) to assist priority setting in stroke. Stroke 2004;35:1041-1046.
    • (2004) Stroke , vol.35 , pp. 1041-1046
    • Moodie, M.L.1    Carter, R.2    Mihalopoulos, C.3    Thrift, A.G.4    Chambers, B.R.5    Donnan, G.A.6
  • 19
    • 24344467365 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of thrombolytic treatment for stroke
    • Mar J, Begiristain JM, Arrazola A. Cost-effectiveness analysis of thrombolytic treatment for stroke. Cerebrovasc Dis 2005;20:193-200.
    • (2005) Cerebrovasc Dis , vol.20 , pp. 193-200
    • Mar, J.1    Begiristain, J.M.2    Arrazola, A.3
  • 20
    • 33845918908 scopus 로고    scopus 로고
    • Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke
    • Ehlers L, Andersen G, Clausen LB, Bech M, Kjolby M. Cost-effectiveness of intravenous thrombolysis with alteplase within a 3-hour window after acute ischemic stroke. Stroke 2007;38:85-89.
    • (2007) Stroke , vol.38 , pp. 85-89
    • Ehlers, L.1    Andersen, G.2    Clausen, L.B.3    Bech, M.4    Kjolby, M.5
  • 21
    • 0032519289 scopus 로고    scopus 로고
    • Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: An assessment of currently available literature
    • Wade WE. Cost-effectiveness of venous thrombosis prophylaxis following ischemic stroke: an assessment of currently available literature. Thromb Res 1998;89:199-202.
    • (1998) Thromb Res , vol.89 , pp. 199-202
    • Wade, W.E.1
  • 22
    • 0034626359 scopus 로고    scopus 로고
    • Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack
    • Sarasin FP, Gaspoz JM, Bounameaux H. Cost-effectiveness of new antiplatelet regimens used as secondary prevention of stroke or transient ischemic attack. Arch Intern Med 2000;160:2773-2778.
    • (2000) Arch Intern Med , vol.160 , pp. 2773-2778
    • Sarasin, F.P.1    Gaspoz, J.M.2    Bounameaux, H.3
  • 23
    • 27744576942 scopus 로고    scopus 로고
    • Cost-effectiveness of antiplatelet agents in secondary stroke prevention: The limits of certainty
    • Matchar DB, Samsa GP, Liu S. Cost-effectiveness of antiplatelet agents in secondary stroke prevention: the limits of certainty. Value He-alth 2005;8:572-580.
    • (2005) Value He-alth , vol.8 , pp. 572-580
    • Matchar, D.B.1    Samsa, G.P.2    Liu, S.3
  • 24
    • 0034003929 scopus 로고    scopus 로고
    • Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: A cost-effectiveness analysis
    • Shah H, Gondek K. Aspirin plus extended-release dipyridamole or clopidogrel compared with aspirin monotherapy for the prevention of recurrent ischemic stroke: a cost-effectiveness analysis. Clin Ther 2000; 22:362-370.
    • (2000) Clin Ther , vol.22 , pp. 362-370
    • Shah, H.1    Gondek, K.2
  • 26
    • 0029957548 scopus 로고    scopus 로고
    • Rehabilitation after stroke: Cost-effectiveness analyses
    • Keith RA. Rehabilitation after stroke: cost-effectiveness analyses. J R Soc Med 1996;89:631-633.
    • (1996) J R Soc Med , vol.89 , pp. 631-633
    • Keith, R.A.1
  • 28
    • 1442299258 scopus 로고    scopus 로고
    • Estimating the cost-effectiveness of stroke units in France compared with conventional care
    • Launois R, Giroud M, Mégnigbêto AC, Le Lay K, Présenté G, Mahagne MH, et al. Estimating the cost-effectiveness of stroke units in France compared with conventional care. Stroke 2004;35:770-775.
    • (2004) Stroke , vol.35 , pp. 770-775
    • Launois, R.1    Giroud, M.2    Mégnigbêto, A.C.3    Le Lay, K.4    Présenté, G.5    Mahagne, M.H.6
  • 29
    • 34247844511 scopus 로고    scopus 로고
    • The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists
    • Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups
    • Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A, et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Stroke 2007;38:1655-1711.
    • (2007) Stroke , vol.38 , pp. 1655-1711
    • Adams Jr., H.P.1    del Zoppo, G.2    Alberts, M.J.3    Bhatt, D.L.4    Brass, L.5    Furlan, A.6
  • 31
    • 0033057012 scopus 로고    scopus 로고
    • A systematic review of cost-effectiveness research of stroke evaluation and treatment
    • Holloway RG, Benesch CG, Rahilly CR, Courtright CE. A systematic review of cost-effectiveness research of stroke evaluation and treatment. Stroke 1999;30:1340-1349.
    • (1999) Stroke , vol.30 , pp. 1340-1349
    • Holloway, R.G.1    Benesch, C.G.2    Rahilly, C.R.3    Courtright, C.E.4
  • 32
    • 5344243751 scopus 로고    scopus 로고
    • Cost-effectiveness analysis of tissue plasminogen activator for acute ischemic stroke: A comparative review
    • Tseng MC, Chang KC. Cost-effectiveness analysis of tissue plasminogen activator for acute ischemic stroke: a comparative review. Acta Neurol Taiwan 2004;13:149-155.
    • (2004) Acta Neurol Taiwan , vol.13 , pp. 149-155
    • Tseng, M.C.1    Chang, K.C.2
  • 33
    • 84903867482 scopus 로고    scopus 로고
    • Korean Exchange Bank. [cited]; Available from
    • Korean Exchange Bank. [cited]; Available from: http://inflationdata.com/.
  • 34
    • 84903875592 scopus 로고    scopus 로고
    • Inflationdata.com. [cited]; Available from
    • Inflationdata.com. [cited]; Available from: http://inflationdata.com/.
  • 36
    • 39749111776 scopus 로고    scopus 로고
    • Impact of functional status at six months on long term survival in patients with ischaemic stroke: Prospective cohort studies
    • Oxfordshire Community Stroke Project, the International Stroke Trial (UK): Lothian Stroke Register
    • Slot KB, Berge E, Dorman P, Lewis S, Dennis M, Sandercock P; Oxfordshire Community Stroke Project, the International Stroke Trial (UK): Lothian Stroke Register. Impact of functional status at six months on long term survival in patients with ischaemic stroke: prospective cohort studies. BMJ 2008;336:376-379.
    • (2008) BMJ , vol.336 , pp. 376-379
    • Slot, K.B.1    Berge, E.2    Dorman, P.3    Lewis, S.4    Dennis, M.5    Sandercock, P.6
  • 37
    • 44449156444 scopus 로고    scopus 로고
    • Functional outcome 3 months after stroke predicts long-term survival
    • Eriksson M, Norrving B, Terént A, Stegmayr B. Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008; 25:423-429.
    • (2008) Cerebrovasc Dis , vol.25 , pp. 423-429
    • Eriksson, M.1    Norrving, B.2    Terént, A.3    Stegmayr, B.4
  • 38
    • 0032541845 scopus 로고    scopus 로고
    • Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (EC-ASS II). Second European-Australasian Acute Stroke Study Investigators
    • Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (EC-ASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245-1251.
    • (1998) Lancet , vol.352 , pp. 1245-1251
    • Hacke, W.1    Kaste, M.2    Fieschi, C.3    von Kummer, R.4    Davalos, A.5    Meier, D.6
  • 40
    • 70449601229 scopus 로고    scopus 로고
    • Are in-Hospital Delays Important Obstacles In Thrombolytic Therapy Following Acute Ischemic Stroke?
    • Choi JC, Kang SY, Kang JH, Ko YJ, Bae JM. Are in-Hospital Delays Important Obstacles In Thrombolytic Therapy Following Acute Ischemic Stroke? J Clin Neurol 2007;3:71-78.
    • (2007) J Clin Neurol , vol.3 , pp. 71-78
    • Choi, J.C.1    Kang, S.Y.2    Kang, J.H.3    Ko, Y.J.4    Bae, J.M.5
  • 41
    • 77953356688 scopus 로고    scopus 로고
    • Multimodal MRI for ischemic stroke: From acute therapy to preventive strategies
    • Bang OY. Multimodal MRI for ischemic stroke: from acute therapy to preventive strategies. J Clin Neurol 2009;5:107-119.
    • (2009) J Clin Neurol , vol.5 , pp. 107-119
    • Bang, O.Y.1
  • 42
    • 18844477380 scopus 로고    scopus 로고
    • Recommendations for the establishment of primary stroke centers. Brain Attack Coalition
    • Alberts MJ, Hademenos G, Latchaw RE, Jagoda A, Marler JR, Mayberg MR, et al. Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA 2000;283:3102-3109.
    • (2000) JAMA , vol.283 , pp. 3102-3109
    • Alberts, M.J.1    Hademenos, G.2    Latchaw, R.E.3    Jagoda, A.4    Marler, J.R.5    Mayberg, M.R.6
  • 43
    • 22044445060 scopus 로고    scopus 로고
    • Recommendations for comprehensive stroke centers: A consensus statement from the Brain Attack Coalition
    • Alberts MJ, Latchaw RE, Selman WR, Shephard T, Hadley MN, Brass LM, et al. Recommendations for comprehensive stroke centers: a consensus statement from the Brain Attack Coalition. Stroke 2005;36: 1597-1616.
    • (2005) Stroke , vol.36 , pp. 1597-1616
    • Alberts, M.J.1    Latchaw, R.E.2    Selman, W.R.3    Shephard, T.4    Hadley, M.N.5    Brass, L.M.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.